S L Nightingale. Show Affiliations »
Abstract
Mesh: See more » Drug ApprovalErythema Nodosum/drug therapyHumansLeprostatic Agents/therapeutic useLeprosy, Lepromatous/drug therapyPolicy MakingThalidomide/therapeutic useUnited StatesUnited States Food and Drug Administration/organization & administration
Substances: See more » Leprostatic AgentsThalidomide
Year: 1998 PMID: 9739956 DOI: 10.1001/jama.280.10.872-jfd80008-2-1
Source DB: PubMed Journal: JAMA ISSN: 0098-7484 Impact factor: 56.272